Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)

SHE:002252 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,037	2,983	4,001	3,978	2,747	1,953
Trading Asset Securities	-	-	197.41	237.77	219.38	262.14
Cash & Short-Term Investments	4,037	2,983	4,199	4,216	2,966	2,215
Cash Growth	-18.06%	-28.95%	-0.40%	42.11%	33.90%	27.92%
Accounts Receivable	2,187	1,810	774.08	915.44	649.52	580.2
Other Receivables	190.17	1.89	8.22	2.02	1.21	0.17
Receivables	2,377	1,812	782.3	917.46	650.73	580.37
Inventory	4,120	4,293	3,667	3,269	3,173	2,163
Prepaid Expenses	-	7.7	0.07	0.1	0.14	0.13
Other Current Assets	147.17	162.02	27.21	71.41	81.69	53.09
Total Current Assets	10,681	9,257	8,675	8,473	6,872	5,012
Property, Plant & Equipment	1,944	1,922	1,453	1,282	1,279	1,229
Long-Term Investments	15,484	16,777	16,177	15,702	13,878	13,678
Goodwill	5,073	5,073	5,073	4,703	4,900	5,261
Other Intangible Assets	475.08	485.01	233.85	175.49	163.18	172.42
Long-Term Deferred Tax Assets	71.2	75.14	89.81	83.55	104.27	96.35
Long-Term Deferred Charges	27.38	28.47	21.29	25.78	28.97	33.17
Other Long-Term Assets	926.41	12.22	205.34	13	11.54	11.71
Total Assets	34,682	33,631	31,928	30,458	27,237	25,494
Accounts Payable	1,636	1,076	1,651	1,130	956.29	87
Accrued Expenses	91.5	346.84	289.17	275.36	234.64	183.88
Short-Term Debt	24.72	-	-	-	-	7.74
Current Portion of Leases	4.66	4.61	0.41	1.98	4.09	-
Current Income Taxes Payable	74.18	25.94	94.57	91.03	53.53	7.8
Current Unearned Revenue	7.74	4.69	22.64	91.76	28.69	10.88
Other Current Liabilities	291.71	193.18	186.97	34.54	29.38	32.93
Total Current Liabilities	2,130	1,652	2,245	1,625	1,307	330.24
Long-Term Leases	12.27	12.99	1.49	1.85	4.16	-
Long-Term Unearned Revenue	10.66	10.96	9.49	12.77	15.2	25.31
Long-Term Deferred Tax Liabilities	14.54	14.82	16.02	5.34	6.44	8.19
Other Long-Term Liabilities	-	-	7.06	-	-	-
Total Liabilities	2,168	1,691	2,279	1,645	1,332	363.73
Common Stock	6,638	6,638	6,645	6,741	6,741	6,741
Additional Paid-In Capital	14,065	14,058	13,805	14,560	14,560	14,558
Retained Earnings	11,425	10,859	9,110	7,533	5,843	4,715
Treasury Stock	-77.18	-77.18	-182.92	-	-	-
Comprehensive Income & Other	448.93	448.62	255.67	-15.72	-1,241	-891.49
Total Common Equity	32,500	31,926	29,634	28,819	25,902	25,123
Minority Interest	14.6	14.46	15.86	-5.37	1.72	7.28
Shareholders' Equity	32,515	31,941	29,650	28,813	25,904	25,130
Total Liabilities & Equity	34,682	33,631	31,928	30,458	27,237	25,494
Total Debt	41.66	17.59	1.91	3.82	8.25	7.74
Net Cash (Debt)	3,995	2,965	4,197	4,212	2,958	2,208
Net Cash Growth	-18.87%	-29.34%	-0.36%	42.38%	34.00%	27.48%
Net Cash Per Share	0.60	0.45	0.64	0.62	0.44	0.34
Filing Date Shares Outstanding	6,660	6,617	6,605	6,741	6,741	6,741
Total Common Shares Outstanding	6,660	6,617	6,605	6,741	6,741	6,741
Working Capital	8,551	7,606	6,431	6,849	5,566	4,682
Book Value Per Share	4.88	4.83	4.49	4.28	3.84	3.73
Tangible Book Value	26,951	26,368	24,327	23,940	20,839	19,689
Tangible Book Value Per Share	4.05	3.99	3.68	3.55	3.09	2.92
Buildings	-	1,661	1,343	1,195	1,146	1,016
Machinery	-	1,287	1,216	1,132	1,074	988.43
Construction In Progress	-	289.21	134.03	74.19	26.89	105.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.